No­vo Nordisk calls IRA 'un­prece­dent­ed de­par­ture' from US Con­sti­tu­tion

No­vo Nordisk re­quest­ed last week that a New Jer­sey fed­er­al court strike down CMS guid­ance around Medicare price ne­go­ti­a­tions, ar­gu­ing that no law has giv­en a gov­ern­ment agency such broad pric­ing au­thor­i­ty “even dur­ing wartime.”

The Dan­ish phar­ma said in a mo­tion for sum­ma­ry judg­ment that CMS’ guid­ance vi­o­lates the In­fla­tion Re­duc­tion Act’s “plain text” by group­ing No­vo Nordisk’s in­sulin as­part prod­ucts to­geth­er. No­vo al­so chal­lenged what it claims are “grave un­der­ly­ing con­sti­tu­tion­al prob­lems” with the leg­is­la­tion, in­clud­ing an al­leged lack of “ad­e­quate pro­ce­dures to pro­tect against un­fair and con­fis­ca­to­ry pric­ing.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER